Preparation of (14R)-8-[3-(2-{dispiro[2.0.2.1]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2lambda6-thia-3,9,11,18,23-pentaazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione;BDBM644781;HY-145603A;CS-0930642;(R)-Vanzacaftor;SCHEMBL21256891;2374124-48-6;US11866450, Compound 194
Solubility
DMSO : 125 mg/mL (279.06 mM; ultrasonic and warming and heat to 60°C)
Shipping and Storage
Store Temp
Room temperature in continental US; may vary elsewhere.
Ship Temp
Powder:3 years -20°C。In solvent:1 years -80°C
References
No References!
Get HPLC
Your information is safe with us.
*Indicates a Required Field
Get HNMR
Your information is safe with us.
*Indicates a Required Field
Get COA
Your information is safe with us.
*Indicates a Required Field